BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Psychiatry. Aug 19, 2026; 16(8): 119250
Published online Aug 19, 2026. doi: 10.5498/wjp.119250
Figure 1
Figure 1 The patient screening and inclusion process. HADS: Hospital Anxiety and Depression Scale.
Figure 2
Figure 2 Comparison of baseline patient characteristics. HADS-A: Hospital Anxiety and Depression Scale-anxiety subscale; MARS: Medication Adherence Reporting Scale; NAS: Nursing Activity Rating Scale.
Figure 3
Figure 3 Multivariate linear regression analysis of the impact of anxiety/depression status on primary outcome indicators. MARS: Medication Adherence Reporting Scale; NAS: Nursing Activity Rating Scale; CRP: C-reactive protein; NS: Not significant.
Figure 4
Figure 4 Dose-response relationship analysis of anxiety (Hospital Anxiety and Depression Scale-anxiety subscale) and depression (Hospital Anxiety and Depression Scale-depression subscale) symptom scores on primary outcomes. HADS-A: Hospital Anxiety and Depression Scale-anxiety subscale; HADS-D: Hospital Anxiety and Depression Scale-depression subscale; MARS: Medication Adherence Reporting Scale.


Write to the Help Desk